|
TMTC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.974200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.075600E-01 |
| Normal-vs-Stage2 |
6.446800E-01 |
| Normal-vs-Stage3 |
6.608000E-02 |
| Normal-vs-Stage4 |
1.622960E-01 |
| Stage1-vs-Stage2 |
9.424600E-01 |
| Stage1-vs-Stage3 |
1.376100E-02 |
| Stage1-vs-Stage4 |
1.266960E-01 |
| Stage2-vs-Stage3 |
8.292400E-02 |
| Stage2-vs-Stage4 |
1.317980E-01 |
| Stage3-vs-Stage4 |
5.841600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.537800E-01 |
| Normal-vs-AfricanAmerican |
5.174600E-01 |
| Normal-vs-Asian |
4.016000E-01 |
| Caucasian-vs-AfricanAmerican |
6.184800E-01 |
| Caucasian-vs-Asian |
4.424400E-01 |
| AfricanAmerican-vs-Asian |
5.393600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.516400E-01 |
| Normal-vs-Female |
2.396000E-02 |
| Male-vs-Female |
7.937800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.530600E-01 |
| Normal-vs-Extreme_Weight |
9.254200E-02 |
| Normal-vs-Obese |
2.776000E-01 |
| Normal-vs-Extreme_Obese |
5.779400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.102600E-01 |
| Normal_Weight-vs-Obese |
4.385600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.233200E-01 |
| Extreme_Weight-vs-Obese |
2.259600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.531600E-01 |
| Obese-vs-Extreme_Obese |
3.587800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.539900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.245900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.737620E-01 |
| Normal-vs-Age(81-100Yrs) |
4.550200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.679600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.758400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.119800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.979940E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.682430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.779200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.329200E-01 |
| Normal-VS-Type2 PRCC |
9.759200E-01 |
| Normal-VS-KIRP CIMP |
5.685900E-02 |
| Normal-VS-Unclassified PRCC |
2.642600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.255000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.595000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.820400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.333840E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.543000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.776440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.232000E-01 |
| Normal-vs-N1 |
1.878130E-02 |
| Normal-vs-N2 |
3.940200E-01 |
| N0-vs-N1 |
1.681930E-02 |
| N0-vs-N2 |
2.007800E-01 |
| N1-vs-N2 |
7.889200E-01 |
|
|
